图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
国际药用蘑菇期刊
影响因子: 1.423 5年影响因子: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN 打印: 1521-9437
ISSN 在线: 1940-4344

国际药用蘑菇期刊

DOI: 10.1615/IntJMedMushr.v11.i3.60
pages 269-279

Antibacterial Properties of Selected Lignicolous Mushrooms and Fungi from Northern Serbia

Maja Karaman
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg D. Obradovica 2, Novi Sad 21000
Neda Mimica-Dukic
Department of Chemistry, Faculty of Sciences, University of Novi Sad, Trg D. Obradovica 3, Novi Sad 21000, Serbia
Petar Knezevic
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg D. Obradovica 2, Novi Sad 21000, Serbia
Zorica Svircev
Faculty of Natural Sciences, University of Novi Sad, Novi Sad, Serbia and Montenegro
Milan Matavuly
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg D. Obradovica 2, Novi Sad 21000, Serbia

ABSTRACT

Antibacterial activity of organic extracts (70% methanol, 100% chloroform) from 10 lignicolous mushroom and fungal species—Meripilus giganteus, Laetiporus sulphureus, Coriolus versicolor, Flammulina velutipes, Ganoderma lucidum, G. applanatum, Pleurotus ostreatus, Piptoporus betulinus, Panus tigrinus, and Fistulina hepatica—was analyzed against 18 strains of bacteria using the agar-well diffusion assay. The level of antimicrobial effect was determined by dilution susceptibility tests in micro-plates. Antibiotic susceptibility assay of the bacterial strains to common antibiotics was done with the disk-diffusion method. The extracts of Piptoporus betulinus were the most active. The examined extracts, including M. giganteus and P. tigrinus, which were tested for the first time, inhibited mostly Gram-positive bacteria (Bacillus sp., Rhodococcus equi, and Staphylococcus aureus) resistant to common antibiotics. Minimal inhibitory concentrations ranged from 17.5 to 9000 μg/mL. The results demonstrate that lignicolous mushrooms and fungi may be rich sources for new biologically active products.